Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19

AIM: The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants. MATERIALS & METHODS: This study was performed on 330 COVID-19 patients, including 142 with severe and 188 wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavakoli, Rezvan, Rahimi, Pooneh, Hamidi-Fard, Mojtaba, Eybpoosh, Sana, Doroud, Delaram, Ahmadi, Iraj, Anvari, Enayat, Aghasadeghi, Mohammadreza, Fateh, Abolfazl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348059/
http://dx.doi.org/10.2217/fvl-2022-0210
Descripción
Sumario:AIM: The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants. MATERIALS & METHODS: This study was performed on 330 COVID-19 patients, including 142 with severe and 188 with mild infections, as well as 160 healthy controls. The levels of TRIM56 gene expression were determined using a qPCR. RESULTS: TRIM56 gene showed significantly lower mRNA expression in the severe and mild groups compared with healthy individuals. Our finding indicated the high and low reduction of TRIM56 mRNA expression in Delta and Omicron BA.5 variant, respectively. CONCLUSION: Further research is needed to characterize the impact of TRIM proteins on the severity of COVID-19.

Ejemplares similares